An international fertilizer business in Augusta Township is going to pot.

V6 Agronomy has developed a fertilizer kit for home-growers of marijuana to capitalize on what is expected to become a growth industry once cannabis is legalized in Canada this summer.

The husband-and-wife team of Ryan Brophy and Amy Fogo has developed a small three-stage kit designed with the home-grower in mind.

For $19.99 plus tax, they will sell three pouches of different fertilizers, measuring spoons and instructions to guide budding growers on the care and feeding of their plants. The kits will contain enough fertilizer for two marijuana plants. (Under Bill C-45, Canadians would be allowed to cultivate four marijuana plants at home for personal use.)

The OTCMarkets were mixed on Thursday afternoon, with the OTCQX US and the OTCQB Venture slightly down.

Block One Capital Inc (OTCQB:BKPPF) announced the completion of a US$2mln non-brokered placement. The blockchain investment company plans to put the money towards its investment portfolio. Shares of the Vancouver-based company were up 5.4% in afternoon trading.

Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues to expand its extensive intellectual property portfolio through the recent filing of 3 additional US patent applications and 1 international (Patent Cooperation Treaty or "PCT") application. Canntab's portfolio now includes 11 patent applications in the United States and internationally. These filings, which include 7 non-provisional US patent application and 4 PCT patent applications, build on Canntab's growing intellectual property portfolio, which already included 7 provisional US patent applications and 10 trademark applications in the United States and Canada.

Three 8-week online courses now available in both English and French.

A post secondary school based in Sudbury plans to capitalize on the emerging cannabis industry, which is expected to grow significantly once the federal government legalizes marijuana later this summer.

Collège Boréal has launched three online courses in cannabis training. The courses are each eight weeks long and are available in both English and French.

"With the cannabis industry obviously in a boom, and the upcoming legislation that's around the corner, there is a very high demand for trained professionals," Julie Nadeau, director of Contract Training said.

About 63 per cent of the licensed medical cannabis producers surveyed said they’d “very likely” seek American venture capital compared with 23 per cent who would "very likely" seek Canadian venture capital.

Canadian cannabis companies are hungry for U.S. private investment, according to a survey conducted by Statistics Canada looking at the state of the marijuana industry.

Are Canadian legalization laws too strict to be worth the effort?

Legalizing marijuana in Canada will benefit millions of people. First and foremost, people will no longer be incarcerated for minor possession charges. This means fewer arrest records, less government spending on prisons and less longterm impact on the careers and lives of those caught with marijuana. Legalization does, however, vary province by province, and come with a host of bureaucratic complications. Are Canadian legalization laws too strict? Here’s a closer look at the problems marijuana legislation, as it exists today, could cause.

Strict Laws Require Bigger Law Enforcement Budgets

Companies are falling short when it comes to having comprehensive policies on substance use, according to a new report by the Canadian Centre on Substance Use and Addiction.

The report, which is based on a review of about 800 companies, interviews with experts and responses to an online survey, aimed to analyze and provide a general overview of the state of workplace policies on substance use as Canada moves towards the legalization and regulation of cannabis this summer. It found that while most respondents had a specific policy on employee alcohol and drug use, there’s a particular gap when it comes to medical marijuana. It was the only substance that the majority (55 per cent) of respondents indicated wasn’t part of their organization’s policy on substance use.

An unexpected drama played out at a conference centre in Toronto recently, beginning with a presentation about the future of medical marijuana and ending in insults, jeers and a minor Twitter storm. At the heart of the dispute was a question that producers and users of medical cannabis feel strongly about: Once recreational pot is legal, should there still be a separate medical marijuana system?

Dixie Brands Inc., a U.S. maker of marijuana beverages, is considering an initial public offering toward the end of this year or early next year as it seeks capital for expansion and acquisitions. The company, which hasn’t mandated bankers yet, is eyeing a listing in Canada, Chief Executive Officer Chuck Smith said Thursday in an interview on the sidelines of the Cannabis Invest U.K. conference in London. Dixie will have about $20 million in revenue this year and up to about $50-million in 2019, Smith said. “We need access to capital, we need liquidity because this growth is very expensive,” said Smith, who founded the company in 2009 and remains its majority shareholder. “We’re going to continue to acquire brands or innovate them.”

In case you haven’t noticed, the legal marijuana movement is creating quite the buzz on Wall Street. Since the start of 2016, a number of the largest pot companies by market cap have seen their share prices rise by more than 1,000%.

It has to do with a combination of rapidly growing sales, a consistent shift in the public’s opinion on cannabis, and a “marijuana first” expected out of Canada later this year.

But it’s not just sales growth that has investors excited. It’s the shift in consumer opinion toward cannabis.  With the public strongly behind the idea of legalization, investors expect sales growth throughout North America to continue climbing.

Investing in Canadian marijuana stocks two years ago would have been a dream for most investors.